Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Changes in physical characteristics of regulatory T cell can predict MDS progression risk

Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.

13 Sep 2012

Angiopoietin-like protein 2 level linked to incident diabetes

Elevated angiopoietin-like protein 2 levels are associated with the development of Type 2 diabetes, show findings from a Japanese study.

12 Sep 2012

Cardiac stem cells from newborns show stronger regenerative ability

Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat serious heart problems in children, have conducted the first direct comparison of the regenerative abilities of neonatal and adult-derived human cardiac stem cells.

11 Sep 2012

Quality diabetes care comes at a price

Researchers say that the Quality and Outcomes Framework that was introduced to UK general practice in 2004 may not be worth the expense of implementing in terms of benefiting patients.

10 Sep 2012

Acute Cardiac Care Congress to be held in Istanbul, Turkey

More than 400 scientific abstracts will be presented by international scientists, providing a great source of news stories for journalists.

10 Sep 2012

Baylor Health Care System raises awareness about atrial fibrillation

An estimated 2.5 million Americans suffer from irregular heartbeats-also known as atrial fibrillation. Baylor Health Care System is raising awareness about this often misunderstood, but potentially life changing cardiovascular condition whose incidence is on the rise and expected to more than double by 2050.

10 Sep 2012

Increased risk of heart failure and cardiovascular death linked to thickening of heart's right ventricle

Researchers at the Perelman School of Medicine at the University of Pennsylvania report in a new study that thickening of the heart's right ventricle is associated with an increased risk of heart failure and cardiovascular death in patients without clinical cardiovascular disease at baseline. The study is published online ahead of print in the journal Circulation.

7 Sep 2012

Trevena to present TRV027 Phase 1 clinical data at 16th Annual Heart Failure Society of America Meeting

Trevena, Inc., the leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, today announced that it is presenting a poster featuring Phase 1 clinical data on TRV027 at the 16th Annual Heart Failure Society of America Meeting being held in Seattle, WA, September 9th-12th. Trevena is developing TRV027 for the treatment of acute decompensated heart failure.

7 Sep 2012

Gestational diabetes estimates inconsistent among Indigenous, Aboriginal populations

Literature published on the prevalence of gestational diabetes in Indigenous and Aboriginal women is inconsistent and disparate, report researchers.

7 Sep 2012

Unrecognized heart attack prevalent in older diabetes patients

The prevalence of unrecognized myocardial infarction by cardiac magnetic resonance in elderly patients is higher than that of recognized MI and is associated with increased mortality, say researchers.

7 Sep 2012

Untreated severe OSA may increase risk of cardiovascular death in the elderly

Untreated severe obstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular mortality in the elderly, and adequate treatment with continuous positive airway pressure (CPAP) may significantly reduce this risk, according to a new study from researchers in Spain.

7 Sep 2012

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.

6 Sep 2012

SSM Center for Sleep Disorders, NovaSom announce first AccuSom Deliver partnership

NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, announces its first AccuSom Deliver partnership with SSM Center for Sleep Disorders, a service of SSM Health Care - St. Louis, making convenient, efficient Out-of-Center Sleep Testing (OCST) available to patients at seven locations throughout the area beginning October 1, 2012.

6 Sep 2012

Unemployment barrier to antidiabetic medication adherence

People with diabetes are less likely to adhere to their oral antidiabetic medication if they are unemployed, report researchers.

5 Sep 2012

Long-term cardiac impact of Japan quake revealed

The 2011 earthquake and tsunami that devastated parts of north-eastern Japan led to a significantly increased weekly occurrence of cardiovascular disease in the months after the event, study findings show.

5 Sep 2012

More focus required on hospice care for heart failure patients

End-stage heart failure patients enter hospice care closer to the time of their death, are more often referred from acute care facilities, and are more likely to die in acute care settings compared with cancer patients, show study results.

5 Sep 2012

Study evaluates prognostic utility of novel biomarkers of cardiovascular stress

Critical Diagnostics announced today, Circulation, an American Heart Association Journal, released online the first study evaluating the power of ST2 to predict development of heart failure and other adverse outcomes in the general population titled, "Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study".

5 Sep 2012

Avanir initiates enrollment in AVP-923 Phase II clinical trial for treatment of agitation in AD patients

Avanir Pharmaceuticals, Inc. today announced the enrollment of the first patient in study AVR-131. The study is a Phase II clinical trial investigating the use of AVP-923 for the treatment of agitation in patients with Alzheimer's disease.

5 Sep 2012

Lack of evidence to recommend routine screening for chronic kidney disease

Currently there is insufficient evidence to recommend the routine screening of chronic kidney disease in asymptomatic adults in the general population, according to a review by the US Preventive Services Task Force.

4 Sep 2012

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for INLYTA (axitinib) for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

4 Sep 2012

Heart Failure News and Research

Further Reading

Changes in physical characteristics of regulatory T cell can predict MDS progression risk

Angiopoietin-like protein 2 level linked to incident diabetes

Cardiac stem cells from newborns show stronger regenerative ability

Quality diabetes care comes at a price

Acute Cardiac Care Congress to be held in Istanbul, Turkey

Baylor Health Care System raises awareness about atrial fibrillation

Increased risk of heart failure and cardiovascular death linked to thickening of heart's right ventricle

Trevena to present TRV027 Phase 1 clinical data at 16th Annual Heart Failure Society of America Meeting

Gestational diabetes estimates inconsistent among Indigenous, Aboriginal populations

Unrecognized heart attack prevalent in older diabetes patients

Untreated severe OSA may increase risk of cardiovascular death in the elderly

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

SSM Center for Sleep Disorders, NovaSom announce first AccuSom Deliver partnership

Unemployment barrier to antidiabetic medication adherence

Long-term cardiac impact of Japan quake revealed

More focus required on hospice care for heart failure patients

Study evaluates prognostic utility of novel biomarkers of cardiovascular stress

Avanir initiates enrollment in AVP-923 Phase II clinical trial for treatment of agitation in AD patients

Lack of evidence to recommend routine screening for chronic kidney disease

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News